Align Technology Reports Q4 Growth Despite Currency Headwinds and Strong Invisalign Sales
- Align Technology reports Q4 revenues of $995.2 million, with clear aligner sales at $794.3 million.
- The company experiences strong growth in Imaging Systems, generating $200.9 million in Q4 revenue.
- CEO Joe Hogan highlights strong performance despite foreign exchange challenges, focusing on innovation and customer service.
Align Technology Reports Strong Q4 Results Amid Currency Challenges
Align Technology, Inc., a leading global player in the dental technology sector, announces its financial results for the fourth quarter and the year ending December 31, 2024. The company achieves total revenues of $995.2 million for Q4, reflecting a modest 1.8% increase sequentially and a 4.0% rise compared to the same quarter last year. Central to this growth is the performance of its flagship product, the Invisalign® clear aligners, which generates revenues of $794.3 million in Q4, a sequential increase of 0.9% and a year-over-year increase of 1.6%. This upward trajectory in clear aligner sales is complemented by a 1.9% sequential volume increase and a more impressive 6.1% rise year-over-year, underscoring the brand's resilience in a competitive market.
In addition to the clear aligners, Align Technology experiences robust growth in its Imaging Systems and CAD/CAM Services segment, generating $200.9 million in revenue for Q4. This represents a significant 5.2% sequential increase and a remarkable 14.9% increase year-over-year. The company’s operating income for the quarter reaches $144.1 million, yielding a solid operating margin of 14.5%. However, the diluted net income per share of $1.39 faces headwinds from a stronger U.S. dollar, which negatively impacts earnings by approximately $0.14 per share. On a non-GAAP basis, net income stands at $181.6 million, or $2.44 per diluted share, showcasing the company's operational efficiency despite external challenges.
CEO Joe Hogan expresses satisfaction with the Q4 results, highlighting how they align well with the company's forecasts. Hogan emphasizes the strong performance across total revenues, clear aligner volumes, and the Systems and Services segment. As Align Technology navigates the complexities of foreign exchange fluctuations, the company remains committed to maintaining growth in its key areas, indicating a proactive approach to managing financial risks while focusing on innovation and customer service.
In summary, Align Technology concludes the year with total revenues of $4.0 billion, with clear aligner revenues reaching $3.2 billion. Both figures are affected by foreign exchange rates, demonstrating the importance of global market dynamics in the company's financial performance. The results reflect a solid foundation for continued growth in the dental technology industry, as Align Technology leverages its innovative products to meet increasing consumer demand for efficient orthodontic solutions.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…